Metformin has been shown to have some anti-inflammatory effects in clinical studies in patients with T2DM, in experimental studies in rodent models of obesity and T2DM, and in vitro experiments with several immune cells (Foretz et al., 2019
In those preclinical models, BPC-157 has been associated with effects on angiogenesis, on growth-factor expression including VEGF and FGF, and on the nitric oxide system
If you want a quick, researchoriented next step, Tonums research hub gathers trial summaries and product fact sheets that can help you pick an evidencetransparent product
Bryan, N.S., Petrosino, J.F
The first compared GLP-1 receptor agonist users with nonusers among patients with obesity but without type 2 diabetes